Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 17:14:1129793.
doi: 10.3389/fendo.2023.1129793. eCollection 2023.

Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement

Laszlo Rosta  1 , Adrienn Menyhart  2 , Wael Al Mahmeed  3 , Khalid Al-Rasadi  4 , Kamila Al-Alawi  5 , Maciej Banach  6   7   8 , Yajnavalka Banerjee  9 , Antonio Ceriello  10 , Mustafa Cesur  11 , Francesco Cosentino  12 , Alberto Firenze  13 , Massimo Galia  14 , Su-Yen Goh  15 , Andrej Janez  16 , Sanjay Kalra  17 , Nitin Kapoor  18   19 , Nader Lessan  20 , Paulo Lotufo  21 , Nikolaos Papanas  22 , Ali A Rizvi  23 , Amirhossein Sahebkar  24   25   26 , Raul D Santos  27   28 , Anca Pantea Stoian  29 , Peter P Toth  30 , Vijay Viswanathan  31 , Peter Kempler  2 , Manfredi Rizzo  9   29   32
Affiliations
Review

Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement

Laszlo Rosta et al. Front Endocrinol (Lausanne). .

Abstract

The past two decades have witnessed telemedicine becoming a crucial part of health care as a method to facilitate doctor-patient interaction. Due to technological developments and the incremental acquisition of experience in its use, telemedicine's advantages and cost-effectiveness has led to it being recognised as specifically relevant to diabetology. However, the pandemic created new challenges for healthcare systems and the rate of development of digital services started to grow exponentially. It was soon discovered that COVID-19-infected patients with diabetes had an increased risk of both mortality and debilitating sequelae. In addition, it was observed that this higher risk could be attenuated primarily by maintaining optimal control of the patient's glucose metabolism. As opportunities for actual physical doctor-patient visits became restricted, telemedicine provided the most convenient opportunity to communicate with patients and maintain delivery of care. The wide range of experiences of health care provision during the pandemic has led to the development of several excellent strategies regarding the applicability of telemedicine across the whole spectrum of diabetes care. The continuation of these strategies is likely to benefit clinical practice even after the pandemic crisis is over.

Keywords: COVID - 19; diabetes care; diabetes prevention and control; glucose monitoring; telemedicine; type-2 diabetes (T2DM).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
How does the EESZT (National eHealth Infrastructure) services support healthcare.
Figure 2
Figure 2
One Dose Health comparing 6 months follow up results.
See this image and copyright information in PMC

References

    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: a retrospective cohort study. Lancet (2020) 395:1054–62. doi: 10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed
    1. Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C. Clinical characteristics and outcomes of patients with diabetes andCOVID-19 in association with glucose-lowering medication. Diabetes Care (2020) 43:1399–407. doi: 10.2337/dc20-0660 - DOI - PubMed
    1. Mantovani A, Byrne CD, Zheng M-H, Targher G. Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies. Nutr Metab Cardiovasc Dis (2020) 30:1236–48. doi: 10.1016/j.numecd.2020.05.014 - DOI - PMC - PubMed
    1. Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol (2020) 8:823–33. doi: 10.1016/S2213-8587(20)30271-0 - DOI - PMC - PubMed
    1. Kempler P, Zs Gaál, Zs Hermányi, Lengyel Cs. COVID-19 és diabétesz: a halálos páros. fókuszban a vércukor. Metabolizmus (2021) 19(2):60–4.